Poway, CA, United States of America

Cornelis A Rijnbrand

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Avi Biopharma, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cornelis A Rijnbrand. Retrieved from https://idiyas.com/inventor/cornelis-a-rijnbrand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Cornelis A Rijnbrand

Introduction: Cornelis A Rijnbrand is a visionary inventor based in Poway, California, known for his groundbreaking contributions to various fields.

Latest Patents: Cornelis A Rijnbrand holds several patents in the areas of renewable energy technologies, medical devices, and advanced materials.

Career Highlights: With a career spanning over two decades, Rijnbrand has established himself as a leading figure in the innovation landscape. His work has significantly impacted industries such as healthcare, clean energy, and manufacturing.

Collaborations: Throughout his career, Cornelis A Rijnbrand has collaborated with top research institutions, universities, and companies to bring his inventions to life. His collaborative spirit has led to the development of cutting-edge technologies with real-world applications.

Conclusion: Cornelis A Rijnbrand's passion for innovation and his relentless pursuit of excellence continue to drive him towards creating solutions that have the potential to shape the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…